The Motley Fool

Home/Tag: The Motley Fool

The Stash, Volume 51: Cannabis deal making continues to struggle as cash crunch intensifies

CANNABIS DEAL MAKING CONTINUES TO STRUGGLE AS CASH CRUNCH INTENSIFIES In our Dec. 18, 2019, Stash report, we said that balance sheet strength will matter more than ever in 2020 as the cannabis industry funding environment tightens and deals dry up. Capital market trends in 1H20 validate our thesis. Data from Viridian Capital Advisors shows that [...]

2020-07-15T19:08:41+00:00July 8th, 2020|

The Stash, Volume 49: SSOs outperforming MSOs in brand presence, market share, capital efficiency

SSOs OUTPERFORMING MSOs IN BRAND PRESENCE, MARKET SHARE, CAPITAL EFFICIENCY The distinction between single state operators (SSOs) and multi state operators (MSOs) in the U.S. cannabis industry is unlikely to matter in the long term, but in the near- to medium-term SSOs and state leaders are emerging as winners and are in a better position to [...]

2020-07-15T19:09:39+00:00June 24th, 2020|

The Stash, Volume 48: Russell 3000 rebalancing sets stage for greater institutional ownership of cannabis names

RUSSELL 3000 REBALANCING SETS STAGE FOR GREATER INSTITUTIONAL OWNERSHIP OF CANNABIS NAMES We believe the inclusion of GrowGeneration Corp. (GRWG) and Akerna (KERN) in the Russell 3000 index is indicative of the rising interest of institutional investors in the cannabis space. GrowGeneration, the largest chain of stand-alone specialty hydroponic and organic garden centers in the U.S., [...]

2020-07-15T19:10:05+00:00June 19th, 2020|

The Stash, Volume 46: Market Share gains, profitability make Trulieve a standout cannabis name

MARKET SHARE GAINS, PROFITABILITY MAKE TRULIEVE A STANDOUT CANNABIS NAME Trulieve’s (TCNNF) continued market share gains validate our thesis that capital-efficient state leaders are best placed to emerge as winners in the U.S. cannabis market. Our analysis of data from the Florida Office of Medical Marijuana Use suggests that Trulieve’s dominance of Florida’s cannabis market continues [...]

2020-07-15T19:11:03+00:00June 3rd, 2020|

The Stash, Volume 43: Cannabis 2.0 is here and COVID-19 is accelerating the transition

CANNABIS 2.0 IS HERE AND COVID-19 IS ACCELERATING THE TRANSITION Market share gains for marijuana products like edibles and vapor pens in Canada suggest that the transition from Cannabis 1.0 to Cannabis 2.0 is happening at a rapid pace, with stay-at-home restrictions imposed due to COVID-19 acting as an additional catalyst. The launch of cannabis products [...]

2020-07-15T19:12:30+00:00May 13th, 2020|

The Stash, Volume 39: COVID-19 is a Net Positive for Cannabis. Here’s why.

COVID-19 IS A NET POSITIVE FOR CANNABIS. HERE’S WHY. COVID-19’s impact on the cannabis industry is more positive than negative. While COVID-19 is a net negative for most industries, cannabis is among those where the net impact is positive. There are three reasons that bring us to this conclusion: 1) emergence of cannabis as an essential/staple, [...]

2020-04-15T19:48:06+00:00April 15th, 2020|

The Stash, Volume 32: New York Legalization Prospects and the Two Companies Best Placed to Win

NEW YORK LEGALIZATION PROSPECTS AND THE TWO COMPANIES BEST PLACED TO WIN Governor Andrew Cuomo’s efforts to legalize adult-use cannabis, if successful, will make New York one of the top three state markets in the U.S. by 2025. Cuomo – through his FY21 budget – has revived the prospects for legalizing recreational marijuana sales in 2020 [...]

2020-03-30T13:52:29+00:00February 26th, 2020|

The Stash, Volume 30: Innovative Industrial Properties = High Dividend Yield + Strong Earnings Growth

INNOVATIVE INDUSTRIAL PROPERTIES (IIPR) = HIGH DIVIDEND YIELD + STRONG EARNINGS GROWTH Innovative Industrial Properties (IIPR) – the leading cannabis-focused real estate investment trust (REIT) – is one of the best cannabis names for investors to evaluate. IIPR focuses on the acquisition, ownership, and management of specialized industrial properties leased to experienced, state-licensed operators for their [...]

2020-03-30T14:02:15+00:00February 12th, 2020|

The Stash, Volume 29: Canna Finance – Set to Emerge from the Trough of Disillusionment?

CANNA FINANCE: SET TO EMERGE FROM THE TROUGH OF DISILLUSIONMENT? In our Dec. 18, 2019 Stash report, we said that balance sheet strength will matter more than ever in 2020 as the cannabis industry funding environment tightens and deals dry up. We expand on this subject this week by analyzing how cannabis companies went from being [...]

2020-03-30T14:02:42+00:00February 5th, 2020|

The Stash, Volume 28: Medipharm Labs – The Global Cannabis Extraction Leader in the Making

MEDIPHARM LABS: THE GLOBAL CANNABIS EXTRACTION LEADER IN THE MAKING MediPharm Labs (MEDIF) is well positioned to benefit from growth of the global cannabis extraction market to $23.7 billion by 2025. The launch of cannabis products in Canada in December has put the spotlight on Canadian cannabis players and their readiness to benefit from the expansion [...]

2020-03-30T14:03:36+00:00January 29th, 2020|
Go to Top